Dr. Ericsson attended both Uppsala and Stockholm University and obtained his PhD from Stockholm University in 1992. He then moved to the University of California-Los Angeles (UCLA), where he worked on the transcriptional regulation of cholesterol metabolism. 

Dr. Ericsson established his own independent research group in 1998 at the Ludwig Institute for Cancer Research, focusing on the post-translational regulation of a family of transcription factors critical for cholesterol and lipid metabolism, i.e. the SREBP family of proteins. In 2009, Dr. Ericsson became an SFI Stokes Professor at University College Dublin, where his group continued their work on the transcriptional and post-translational regulation of lipid metabolism. Dr. Ericsson has been an Associate Professor at HBKU since May 2019.